MEDIUM confidence: 100% data completeness, but the composite (46) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Avg target $107 (last qtr, 8 analysts) → $100 (last mo, 2) (-6.3%).
Buy-rated share 95% → 92% over ~3 months (-4pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| May 2026 | $-0.68 | $-0.84 | -23.8% |
| Feb 2026 | $-0.71 | $-1.00 | -40.2% |
| Oct 2025 | $-0.88 | $-0.95 | -8.0% |
| Aug 2025 | $-0.83 | $-0.95 | -14.5% |
| Apr 2025 | $-1.00 | $-0.88 | +12.0% |
| Feb 2025 | $-1.09 | $-1.31 | -20.2% |
| Nov 2024 | $-1.03 | $-0.86 | +16.5% |
| Aug 2024 | $-1.09 | $-1.02 | +6.4% |
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $70M— | $78M+11.4% | $9M-88.0% | $222M+2285.3% | $502M+126.3% |
| EPS (dil.) | $-3.90— | $-3.35n/m | $-3.95n/m | $-2.88n/m | $-3.79n/m |
| Free Cash Flow | -$546M— | -$426Mn/m | -$529Mn/m | -$522Mn/m | -$447Mn/m |
| Gross Margin | 95.5% | 95.6%+0.0pp | 73.7%-21.9pp | 98.3%+24.5pp | 94.4%-3.9pp |
| Operating Margin | -827.1% | -659.6%+167.5pp | -6528.8%-5869.1pp | -267.2%+6261.5pp | -113.3%+153.9pp |
| Net Margin | -806.9% | -619.7%+187.2pp | -6913.9%-6294.2pp | -241.4%+6672.5pp | -145.3%+96.2pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Net insider -$29.4M over 180 days (0 open-market buys, 52 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
The QScore of 46 for BBIO suggests a neutral outlook, with the stock's short-term score of 53 diverging from its long-term score of 38. The stock scores high on growth, driven by 126.3% revenue growth, and exhibits strong momentum with a 58.3% return over the past year. However, it trades at a significant discount due to poor profitability, with an operating margin of -98.4% and negative earnings. The stock's risk profile is relatively moderate, with a beta of 1.0 and 60-day volatility of 35.7%.